New Blood Test May Reveal Breast Cancer Relapse Months Before Tumors Form

By Admin at 28 Oct 2015

A new blood test may offer a significantly better option to breast cancer survivors, as it can identify patients at risk of a relapse months before tumors are visible on hospital scans.

0 comments posted

Elevated PSA Level Doesn’t Always Mean Prostate Cancer

By Admin at 26 Oct 2015

Health organizations have long recommended that men begin yearly PSA screening at the age of 50, or even at 40 or 45 if a high risk of prostate cancer was present. This is now controversial, however, in large part because many benign prostate conditions can also cause PSA levels to rise.

0 comments posted

Using Your Own Immune Cells to Cure Blood Cancer

By Admin at 23 Oct 2015

Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults, and although survival rates vary from two to 20 years after diagnosis, it is considered incurable with conventional therapies. While stem cell transplants may provide a cure, not all patients are eligible for the procedure, which is why a new experimental therapy, called CTL019, is raising hope for many.

0 comments posted

Shattering Cancer With Resonant Frequencies

By Admin at 21 Oct 2015

Anthony Holland, PhD, figured out that cancer cells are vulnerable to frequencies between 100,000 hertz and 300,000 hertz. His team tackled pancreatic and leukemia cells, which were similarly destroyed.

0 comments posted

Genetic Testing Helps Unlock the Mystery of Prostate Cancer

By Admin at 19 Oct 2015

Research published in the Journal of Clinical Oncology, revealed 20 genes, or biomarkers, that are associated with prostate cancer. Some of them were also associated with a particularly aggressive form of the disease.

0 comments posted



    2019 2018 2017 2016 2015
    99 cents of every dollar received directly funds cancer clinical trials


    Current Gateway-funded clinical trials


    Clinical trials funded at leading institutions worldwide


    Funds one patient for one day at a Gateway-funded clinical trial


    Mission Partners